×
Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF
$ 40.00
Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF quantity
$ 40.00
×
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF
$ 40.00
Weight Management Program for Treatment-Emergent Weight Gain in Olanzapine-Treated Patients With Schizophrenia or Schizoaffective Disorder: A 12-Week Randomized Controlled Clinical Trial PDF quantity
$ 40.00
×
De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF
$ 40.00
De Novo Emergence of Obsessive-Compulsive Symptoms With Atypical Antipsychotics in Asian Patients With Schizophrenia or Schizoaffective Disorder: A Retrospective, Cross-Sectional Study PDF quantity
$ 40.00
×
Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices PDF
$ 40.00
Combination of Clozapine With Long-Acting Injectable Antipsychotics in Treatment-Resistant Schizophrenia: Preliminary Evidence From Health Care Utilization Indices PDF quantity
$ 40.00
×
Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF
$ 40.00
Clinical Features Distinguishing Patients With Tourette's Syndrome and Obsessive-Compulsive Disorder From Patients With Obsessive-Compulsive Disorder Without Tics PDF quantity
$ 40.00
×
The Safety of Olanzapine Compared With Other Antipsychotic Drugs: Results of an Observational Prospective Study in Patients With Schizophrenia (EFESO Study) PDF
$ 40.00
The Safety of Olanzapine Compared With Other Antipsychotic Drugs: Results of an Observational Prospective Study in Patients With Schizophrenia (EFESO Study) PDF quantity
$ 40.00
×
The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials PDF
$ 40.00
The Effects of Olanzapine on the 5 Dimensions of Schizophrenia Derived by Factor Analysis: Combined Results of the North American and International Trials PDF quantity
$ 40.00
×
Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF
$ 40.00
Depressive and Anxiety Disorders Predicting First Incidence of Alcohol Use Disorders: Results of the Netherlands Study of Depression and Anxiety (NESDA) PDF quantity
$ 40.00
×
Prediction of Recurrence in Recurrent Depression and the Influence of Consecutive Episodes on Vulnerability for Depression: A 2-Year Prospective Study PDF
$ 40.00
Prediction of Recurrence in Recurrent Depression and the Influence of Consecutive Episodes on Vulnerability for Depression: A 2-Year Prospective Study PDF quantity
$ 40.00
×
The Relationship Between Adverse Childhood Experiences and Symptom Severity, Chronicity, and Comorbidity in Patients With Obsessive-Compulsive Disorder PDF
$ 40.00
The Relationship Between Adverse Childhood Experiences and Symptom Severity, Chronicity, and Comorbidity in Patients With Obsessive-Compulsive Disorder PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
